Bio
Douglas W. Blayney, MD is a Professor of Medicine (Oncology) at Stanford, former Medical Director of Stanford Cancer Center, and specializes in the treatment of breast cancer. He has a special interest in the quality and value of cancer care. Dr. Blayney is a past president of the American Society of Clinical Oncology (ASCO), a founder of the ASCO Quality Symposium, a co-author of the ASCO value framework descriptions, and instigated the ASCO clinical "big data" effort, which is now CancerLinQ. He received the inaugural Ellen Stovall Award for Leadership in Patient Centered Care from the National Coalition for Cancer Survivorship in 2016. He was previously a Professor of Internal Medicine and Medical Director of the Comprehensive Cancer Center at the University of Michigan, and prior to that practiced and led Wilshire Oncology Medical Group, Inc. a physician owned multidisciplinary oncology practice in southern California. He has expertise on clinical trial development, use of oncology drugs in clinical practice, reimbursement and marketing strategies and information technology use.
Dr. Blayney's research interests include breast cancer, febrile neutropenia mitigation, and the use big data to improve cancer care quality and value. He has over 90 scientific publications. Dr. Blayney has served on the Food and Drug Administration's Oncologic Drugs Advisory Committee, and is Founding Editor-in-Chief and Editor-in-Chief Emeritus of ASCO's Journal of Oncology Practice. He has a degree in electrical engineering from Stanford, is a graduate of the University of California, San Diego School of Medicine, and received post graduate training at UCSD and at the National Cancer Institute in Bethesda, Maryland.
He is married, and has three grown daughters, one of whom is also a physician.
Clinical Focus
- Cancer > Breast Cancer
- Medical Oncology
- Cancer Care Value and Quality
- Cancer Survivorship
Academic Appointments
-
Professor - Med Center Line, Medicine - Oncology
-
Member, Stanford Cancer Institute
Administrative Appointments
-
President, Wilshire Oncology Medical Group, Inc. (1996 - 2003)
-
Medical Director, University of Michigan Comprehensive Cancer Center (2003 - 2010)
-
Medical Director, Stanford Cancer Center (2010 - 2015)
-
Medical Director for Quality and Outreach, Stanford Cancer Institute (2015 - Present)
Honors & Awards
-
Joseph V. Simone Award for Excellence in Quality and Safety in the Care of Patients with Cancer, American Society of Clinical Oncology (2018)
-
The Ellen Stovall Award for Leadership in Patient-Centered Care, National Coalition for Cancer Survivorship (2016)
-
President, American Society of Clinical Oncology (2009-10)
-
Best Doctors in America, . (2007 - current)
-
Fellow, American Society of Clinical Oncology (2007)
-
Fellow, American College of Physicians (1991)
Professional Education
-
Residency: UCSD Internal Medicine Residency (1980) CA
-
Medical Education: University of California San Diego School of Medicine Registrar (1977) CA
-
Fellowship: National Cancer Institute - Center Cancer Research (1983) MD
-
Board Certification: American Board of Internal Medicine, Medical Oncology (1983)
-
Board Certification: American Board of Internal Medicine, Internal Medicine (1980)
-
Fellowship, Medicine Branch, National Cancer Institute, Bethesda, Maryland (1983)
-
Fellowship, Environmental Epidemiology Branch, National Cancer Institute, Bethesda, Maryland (1983)
-
Resident, University of California Hospitals, San Diego (1980)
-
M.D., University of California, San Diego (1977)
-
B.S.E.E., Stanford University (1972)